Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity

被引:188
|
作者
Yokoo, Sachiko
Yonezawa, Atsushi
Masuda, Satohiro
Fukatsu, Atsushi
Katsura, Toshiya
Inui, Ken-Ichi [1 ]
机构
[1] Kyoto Univ Hosp, Fac Med, Dept Pharm, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ Hosp, Fac Med, Div Artificial Kidneys, Sakyo Ku, Kyoto 6068507, Japan
关键词
cisplatin; MATE1; nephrotoxicity; OCT2; oxaliplatin; renal accumulation;
D O I
10.1016/j.bcp.2007.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanism of severe nephrotoxicity caused by cisplatin, but not carboplatin, oxaliplatin, and nedaplatin, is not fully understood. The renal accumulation and subsequent nephrotoxicity of platinum agents were examined in rats. Among these four drugs, only cisplatin induced nephrotoxicity at 2 days after its intraperitoneal administration. The urinary activity of N-acetyl-beta-D-glucosaminidase and expression of kidney injury molecule-1 mRNA and osteopontin were markedly enhanced in the cisplatin-treated rats. Although some markers were affected in the rats administered nedaplatin, only minor histological change was observed. The renal accumulation of cisplatin was much greater than that of the other drugs. In the in vitro study, the cellular accumulation of cisplatin and oxaliplatin was stimulated by the expression of rat (r) OCT2. Oxaliplatin was also transported by rOCT3. A luminal H+/organic cation antiporter, rMATE1 (multidrug and toxin extrusion) as well as human (h) MATE1 and hMATE2-K, stimulated the H+-gradient-dependent antiport of oxaliplatin, but not of cisplatin. Carboplatin and nedaplatin were not transported by these transporters. In conclusion, the nephrotoxicity of platinum agents was closely associated with their renal accumulation, which is determined by the substrate specificity of the OCT and MATE families. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:477 / 487
页数:11
相关论文
共 50 条
  • [21] Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine
    Mueller, Fabian
    Koenig, Joerg
    Hoier, Eva
    Mandery, Kathrin
    Fromm, Martin F.
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (06) : 808 - 815
  • [22] The Effect of Genetic Variation in OCT1, OCT2 and MATE1 on Metformin Treatment Response
    Van Leeuwen, Nienke
    Nijpels, Giel
    Dekker, Jacqueline M.
    Welschen, Laura
    'T Hart, Leen M.
    DIABETES, 2011, 60 : A387 - A387
  • [23] Polyamine Transport by the Polyspecific Organic Cation Transporters OCT1, OCT2, and OCT3
    Sala-Rabanal, Monica
    Li, Dan C.
    Dake, Gregory R.
    Kurata, Harley T.
    Inyushin, Mikhail
    Skatchkov, Serguei N.
    Nichols, Colin G.
    MOLECULAR PHARMACEUTICS, 2013, 10 (04) : 1450 - 1458
  • [24] Inhibition of the organic cation transporters OCT1 and OCT2 by drugs frequently used in psychiatry
    Muench, K.
    Maas, R.
    Zolk, O.
    Fromm, M. F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 28 - 29
  • [25] INHIBITION OF THE ORGANIC CATION TRANSPORTERS OCT1 AND OCT2 BY 100 FREQUENTLY PRESCRIBED DRUGS
    Muench, K.
    Zolk, O.
    Maas, R.
    Fromm, M. F.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 : 4 - 4
  • [26] EFFECTS OF OCT2 AND MATE1 POLYMORPHISMS AND INHIBITION BY TRIMETHOPRIM ON METFORMIN PHARMACOKINETICS.
    Czock, D.
    Grun, B.
    Kiessling, M.
    Burhenne, J.
    Riedel, K.
    Weiss, J.
    Rauch, G.
    Haefeli, W. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S63 - S64
  • [27] Challenges and Opportunities for Improved Drug-Drug Interaction Predictions for Renal OCT2 and MATE1/2-K Transporters
    Krishnan, Srinivasan
    Ramsden, Diane
    Ferguson, Douglas
    Stahl, Simone H.
    Wang, Joanne
    McGinnity, Dermot F.
    Hariparsad, Niresh
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 562 - 572
  • [28] Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules
    Urakami, Y
    Okuda, M
    Masuda, S
    Akazawa, M
    Saito, H
    Inui, K
    PHARMACEUTICAL RESEARCH, 2001, 18 (11) : 1528 - 1534
  • [29] Distinct Characteristics of Organic Cation Transporters, OCT1 and OCT2, in the Basolateral Membrane of Renal Tubules
    Yumiko Urakami
    Masahiro Okuda
    Satohiro Masuda
    Maiko Akazawa
    Hideyuki Saito
    Ken-ich Inui
    Pharmaceutical Research, 2001, 18 : 1528 - 1534
  • [30] Inhibitory interaction of 125 frequently prescribed drugs with the organic cation transporters OCT1 and OCT2
    Muench, K.
    Zolk, O.
    Monti, J.
    Maas, R.
    Fromm, M. F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S58 - S58